WebinarsNew
Deep DiveNew
Explore Business Standard
Rising air pollution, including fine particulate matter (PM2.5) and ground-level ozone, has prompted calls for India-specific research into its potential contribution to cancer risk, particularly gastrointestinal (GI) cancers, experts have said. While emerging international studies have linked long-term exposure to air pollutants with higher cancer risk, researchers have cautioned that the findings establish associations and do not prove that pollution causes GI cancers or explains the reported rise of cases among younger patients. The issue was discussed at a two-day international conference on colorectal and other GI cancers organised by the Sir Ganga Ram Hospital in collaboration with the United Kingdom's The Christie NHS Foundation Trust here on October 10-11. Dr D S Rana, Chairman, Trust Society, Sir Ganga Ram Hospital, said the international collaboration between the hospital and The Christie NHS Foundation Trust represents an important step towards strengthening medical ...
India had a largely inconsistent growth in clinical research related to cancer since 2001, despite a strong economic growth, suggesting that development could be a contributing factor towards disparities among the low and middle-income countries in cancer research, according to a new study. Cancer cases and deaths are projected to surge in the coming decades with low and middle-income countries expected to bear a disproportionate burden. However, researchers, including those from the the Latin American Cooperative Oncology Group, said that clinical trials of cancer are disproportionally concentrated in high-income countries, even as previous evidence suggests an increase in trials among low and middle-income nations. The study, published in the journal 'CANCER', looked at disparities in the numbers and complexity of clinical trials over time and according to economic changes. Datasets from World Bank and ClinicalTrials.gov were analysed. Between 2001 and 2020, a total of 16,977 can